首页 > 市场调查报告书 > 医疗设备

药物递输设备

肺部药物输送系统市场:各产品类型，各用途，各流通管道，各地区:规模，占有率，展望，机会分析，2023年～2030年

市场调查报告书

商品编码

1349949

肺部药物输送系统市场:各产品类型，各用途，各流通管道，各地区:规模，占有率，展望，机会分析，2023年～2030年

Pulmonary Drug Delivery Systems Market, By Product type, By Application, By Distribution Channel, By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: 2023年07月26日 | 出版商:

Coherent Market Insights | 英文 233 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计到 2023 年，全球肺部给药系统市场将达到 343.4 亿美元，预测期内（2023-2030 年）复合年增长率为 4.6%。Masu。

报告范围		报告详细资料
基准年	2022	2023 年市场规模	美国：343.4亿美元
过去的资料	2018年至2021年	预测期间	2023-2030
预测 2023-2030 年复合年增长率：	4.60%	2030年价值预测	470.5亿美元

肺部给药是病人使用吸入器吸入药物，药物经由肺黏膜吸收到血流中的给药途径。肺部给药在呼吸系统疾病的治疗中提供了直接到达病灶的途径，同时为药物的全身吸收提供了广阔的表面积和相对无?的受控环境。

与静脉、口服、口腔、经皮、阴道、鼻腔和眼部给药相比，肺部给药作为治疗全身性疾病的给药途径具有多种优势。

市场动态

主要市场参与者正专注于有机成长策略，例如监管产品批准，以扩大其产品组合，预计将在预测期内推动全球肺部药物输送系统市场的成长。例如，2020年7月，製药公司诺华公司宣布，欧盟委员会（EC）已批准Enerzair Breezhaler作为成年患者气喘的维持治疗。此次批准还包括一个可选的数位伴侣，带有感测器和应用程序，可提供吸入确认、用药提醒和存取客观数据，以更好地支持治疗决策。

主要市场参与者增加的肺部疾病治疗研发活动预计将在预测期内推动市场成长。例如，2020年12月，专注于透过口腔崩解片技术开发治疗哮喘和慢性阻塞性肺病等呼吸系统疾病具有根本优势的先进吸入製剂的Intas Pharmaceuticals Ltd.宣布正在这样做。此药物输送系统专为快速产品崩解而设计，确保更快起效。该技术已用于多种分子，以方便对儿科、老年和精神病呼吸系统患者的给药，提高患者的依从性，并提供方便的剂量。

本调查的主要特征

本报告提供以2022年为基准年的预测期间（2023-2030 年）之全球肺部药物输送系统市场的市场规模和復合年增长率（CAGR %）相关的详区隔析。
并阐明不同部门市场的潜在收入机会，说明该市场具有魅力的投资主张矩阵。
同时并提供市场推动因素和限制、机会、新产品发布或批准、市场趋势、区域前景和主要参与者采用的竞争战略等重要考察。
并基于企业亮点，各类型投资组合、主要焦点、财务业绩和市场策略等参数，介绍全球肺部药物输送系统市场的主要参与者之企业简介。
藉由该报告提供的洞察，将能帮助营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
全球肺部药物输送系统市场报告配合该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
利益相关者可以透过全球肺部药物输送系统市场用于分析的各种战略矩阵来帮助他们更容易做下决策。

Report Coverage	Report Details
Base Year:	2022	Market Size in 2023:	US$ 34.34 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	4.60%	2030 Value Projection:	US$ 47.05 Bn

Pulmonary drug delivery is a route of administration in which patients use an inhaler to inhale its medications, and drugs are absorbed into the bloodstream via the lung mucous membrane. It provides direct access to disease in the treatment of respiratory diseases, while providing an enormous surface area and a relatively low enzymatic, controlled environment for systemic absorption of medications.

Pulmonary drug delivery offers several advantages as a route of administration for the treatment of systemic diseases compared with intravenous, oral, buccal, transdermal, vaginal, nasal or ocular administration.

Market Dynamics

The key market players are focused on organic growth strategies such as product approval by regulatory authorities to expand its product portfolio is expected to drive the global pulmonary drug delivery systems market growth over the forecast period. For instance, in July 2020, Novartis AG, a pharmaceutical company, announced that the European Commission (EC) has approved Enerzair Breezhaler, as a maintenance treatment of asthma in adult patients. The approval also includes an optional digital companion with sensor and app that provides inhalation confirmation, medication reminders and access to objective data to better support therapeutic decisions.

The increasing research and development activities by key market players for the treatment of pulmonary diseases is expected to drive the market growth over the forecast period. For instance, in December 2020, Intas Pharmaceuticals Ltd., announced that the company was focused on developing advanced inhalation formulation having fundamental advantages in the therapy of diseases of the respiratory tract, including asthma and Chronic Obstructive Pulmonary Disease with Orally Disintegrating Tablet Technology. The Drug delivery system designed for rapid disintegration of the product ensuring faster onset of action. This technology is used for several molecules to facilitate ease of administration and improved patient compliance & convenient dosing for paediatric, geriatric, and psychiatric patients with respiratory diseases.

Key features of the study:

This report provides an in-depth analysis of the global pulmonary drug delivery systems market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global pulmonary drug delivery systems marketbased on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include 3M Health Care, Allied Healthcare Products, Inc., AstraZeneca, Boehringer Ingelheim International GmbH., CareFusion Corporation, GF Health Products, Inc., GlaxoSmithKline plc, Merck & Co., Inc., Novartis AG, Omron Healthcare, Inc., Glenmark Pharmaceuticals, PARI Respiratory Equipment, Inc., and Koninklijke Philips N.V.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global pulmonary drug delivery systems market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pulmonary drug delivery systems market

Detailed Segmentation:

Global Pulmonary Drug Delivery Systems Market, By Product Type:
- Nebulizers
- Dry Powder Inhalers (DPIs)
- Metered Dose Inhalers (MDIs)
Global Pulmonary Drug Delivery Systems Market, By Application:
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- Cystic Fibrosis
- Allergic Rhinitis
- Others
Global Pulmonary Drug Delivery Systems Market, By Distribution Channel:
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Pulmonary Drug Delivery Systems Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
Company Profiles
- 3M Health Care
- Allied Healthcare Products, Inc.
- straZeneca
- Boehringer Ingelheim International GmbH.
- CareFusion Corporation
- GF Health Products, Inc.
- GlaxoSmithKline plc
- Merck & Co., Inc.
- Novartis AG
- Omron Healthcare, Inc.
- Glenmark Pharmaceuticals
- PARI Respiratory Equipment, Inc.
- Koninklijke Philips N.V.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis
Partnership Scenario
Brand and Pricing Analysis
Distributors Landscape
Porters Analysis
Technological Advancements
Key Developments
Market Trend

4. Global Pulmonary Drug Delivery Systems Market- COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Pulmonary Drug Delivery Systems Market, By Product Type, 2018-2030, (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Nebulizers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Segment Trends
Dry Powder Inhalers (DPIs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Segment Trends
Metered Dose Inhalers (MDIs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Segment Trends
- Segment Trends

6. Global Pulmonary Drug Delivery Systems Market, By Application, 2018-2030, (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Asthma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Segment Trends
Chronic Obstructive Pulmonary Disease (COPD)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Segment Trends
Cystic Fibrosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Segment Trends
Allergic Rhinitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Segment Trends
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
- Segment Trends

7. Global Pulmonary Drug Delivery Systems Market, By Distribution Channel, 2018-2030, (US$ Million)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Hospitals Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Million)

8. Global Pulmonary Drug Delivery Systems Market, By Region, 2018-2030, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Regions, 2018-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Million)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product type, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018- 2030, (US$ Million)
North Africa
Central Africa
South Africa

9. Competitive Landscape

3M Health Care
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Allied Healthcare Products, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Boehringer Ingelheim International GmbH.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
CareFusion Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
GF Health Products, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
GlaxoSmithKline plc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Omron Healthcare, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Glenmark Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
PARI Respiratory Equipment, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Koninklijke Philips N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies

10. Section

Research Methodology
About Us

02-2729-4219

+886-2-2729-4219

License/价格

肺部药物输送系统市场:各产品类型，各用途，各流通管道，各地区:规模，占有率，展望，机会分析，2023年～2030年